BMP13 Bone Morphogenetic protein-13 Human Recombinant Protein

CAT:
519-PROTQ6KF10-01
Size:
10 µg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
BMP13 Bone Morphogenetic protein-13 Human Recombinant Protein - image 1

BMP13 Bone Morphogenetic protein-13 Human Recombinant Protein

  • Description:

    BMP13 Human Recombinant produced in E.coli is a non-glycosylated disulfide linked homodimer containing 2 chains of 120 amino acids and having a molecular mass of 27.1kDa. The BMP-13 is purified by proprietary chromatographic techniques.
  • Synonyms:

    Growth Differentiation Factor 6; Growth/Differentiation Factor 16; Bone Morphogenetic Protein 13; BMP-13; BMP13; GDF-6; Klippel-Feil Malformation; Segmentation Syndrome 1; Klip-Feil Malformation; Klippel-Feil Syndrome; MCOPCB6; SCDO4; CDMP2; LCA17; MCOP4; GDF16; KFS1; KFSL; SGM1; KFM; KFS; GDF6
  • Gene Name:

    GDF6
  • UniProt:

    Q6KF10
  • Reactivity:

    Human
  • Source:

    Escherichia coli
  • Sequence:

    [object Object]
  • Purification:

    Greater than 95.0% as determined by (a) Analysis by HPLC. (b) Analysis by SDS-PAGE.
  • Bioactivity:

    50
  • Form:

    Sterile Filtered White lyophilized (freeze-dried) powder.
  • Reconstitution:

    2
  • Function:

    Growth factor that controls proliferation and cellular differentiation in the retina and bone formation. Plays a key role in regulating apoptosis during retinal development. Establishes dorsal-ventral positional information in the retina and controls the formation of the retinotectal map (PubMed:23307924) . Required for normal formation of bones and joints in the limbs, skull, digits and axial skeleton. Plays a key role in establishing boundaries between skeletal elements during development. Regulation of GDF6 expression seems to be a mechanism for evolving species-specific changes in skeletal strucutres. Seems to positively regulates differentiation of chondrogenic tissue through the growth factor receptors subunits BMPR1A, BMPR1B, BMPR2 and ACVR2A, leading to the activation of SMAD1-SMAD5-SMAD8 complex. The regulation of chondrogenic differentiation is inhibited by NOG (PubMed:26643732) . Also involved in the induction of adipogenesis from mesenchymal stem cells. This mechanism acts through the growth factor receptors subunits BMPR1A, BMPR2 and ACVR2A and the activation of SMAD1-SMAD5-SMAD8 complex and MAPK14/p38 (By similarity) .
  • Shipping Conditions:

    Available
  • Storage Conditions:

    Lyophilized BMP13 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution BMP-13 should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA) . Please prevent freeze-thaw cycles.
  • Other Gene Names:

    Growth/differentiation factor 6
  • Subcellular Location:

    Secreted